Revenue per appointment and per fitted patient, conversion, returns and device margin, EBITDA after the owner's salary: one hearing care practice worked line by line.
An audiology practice makes most of its money on hearing aids, so read it per fitted patient and per device kept. In the book's fictional case the first site brought $3,655.39 per fitted patient in FY2026 at a 65.7% hearing aid margin; the practice made $2,159,690 of revenue and $489,106 of EBITDA, 22.6% of revenue, after the owner's $132,000 salary.
Worked in full in The Audiology Practice Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback
Free: the Hearing Care Practice Revenue per Patient and Break-Even Calculator, an Excel workbook that returns revenue per fitted patient and per appointment, the hearing aid gross margin, the devices kept a month to break even and what five more points of conversion are worth.
Asked how much an audiology practice makes, an owner can give three numbers. Revenue is diagnostic fees plus hearing aid sales, after the devices patients returned in their trial period, plus follow-up visits sold separately and accessories, batteries and repairs. EBITDA is what remains after the devices' cost, the staff, rent, overhead and the owner's own salary. What the owner takes home is that salary plus the distributions the cash allows once the loans are paid.
Every figure below comes from Pellastone Hearing Care, the fictional practice of the book: a first site with two sound-treated booths, bought from a retiring audiologist on 1 October 2024, and a second site opened from scratch on 1 April 2026. No industry average is quoted, because none was verified from a primary source. The method is what carries over to your own books.
A hearing care practice runs two economies under one roof. Diagnostic evaluations may be billed to the patient's medical insurance when they are covered: under 42 U.S.C. 1395x(ll), Medicare covers hearing and balance assessment furnished by a qualified audiologist. Hearing aids are a retail sale. Under 42 CFR 411.15(d), as in force in November 2026, Medicare does not pay for hearing aids or for examinations to prescribe, fit or change them, so the device, its fitting and the evaluation to select it are paid by the patient or through a plan's own hearing benefit.
| Line | FY2025 | FY2026 |
|---|---|---|
| Diagnostic fees billed to insurance, net | $55,399 | $78,022 |
| Hearing aid evaluations paid by patients | $42,790 | $61,755 |
| Hearing aids, bundled | $874,200 | $1,349,950 |
| Hearing aids, unbundled devices and fitting fees | $260,000 | $394,250 |
| Hearing aids, third-party contract | $208,750 | $317,500 |
| Refunds on trial returns | −$108,432 | −$163,717 |
| Follow-up visits, accessories and repairs | $78,765 | $121,930 |
| Revenue | $1,411,472 | $2,159,690 |
Hearing aid revenue after returns was 87.5% of revenue in FY2025 and 87.9% in FY2026. Insurers and third-party administrators together paid 16.4% of FY2026 revenue; patients paid the rest at the visit or the fitting.
An appointment is one patient seen by an audiologist on one day; a fitted patient is a new hearing aid patient. At the first site in FY2026:
Revenue per appointment = $1,889,193 ÷ 3,840 appointments = $491.98
Revenue per fitted patient = $1,769,210 (hearing aids after returns, unbundled follow-ups, accessories) ÷ 484 = $3,655.39
Average selling price = $1,662,619 of net hearing aid revenue ÷ 802 devices kept = $2,073.09 a device
How the device is sold changes what one patient is worth. With the case's FY2026 prices and a unit cost of $700, one binaural patient (two devices) before returns:
| Line | Bundled | Unbundled | Third-party |
|---|---|---|---|
| Devices | $4,900 | $3,300 | $2,500 |
| Fitting and follow-ups sold separately | $0 | $1,105 | $0 |
| Cost of two devices | $1,400 | $1,400 | $1,400 |
| Card fees | $127.40 | $114.53 | $0.00 |
| Contribution before staff pay | $3,372.60 | $2,890.47 | $1,100.00 |
The bundled price ($2,450 a device) includes the fitting and the follow-up visits for the life of the warranty; the unbundled patient pays $1,650 a device, a $425 fitting fee per device and $85 a follow-up visit; the third-party administrator pays a $1,250 contract price. The bundled patient's later visits are already paid, the unbundled patient pays each one, a difference the year of the fitting does not show.
The book goes further: seven Excel workbooks (revenue per patient, conversion and hearing aid margin, associate pay, equipment lease or loan, break-even, purchase and SBA loan, offer to cash), each with an exercise and its answer. See The Audiology Practice Owner · PDF, $19.99
The conversion rate is fitted patients divided by diagnostic evaluations. At the first site it was 38.1% in FY2025 and 42.0% in FY2026, with 80% of fitted patients binaural. Of 871 devices fitted in FY2026, 69 came back in their trial period and 802 were kept. Hearing aid revenue after returns of $1,662,619 less the cost of the devices kept and the manufacturer's return fees ($570,355) left a hearing aid gross margin of $1,092,264, 65.7% of hearing aid revenue.
The trap: counting fittings instead of devices kept. A device returned in its trial period is refunded in full, and the manufacturer credits its cost less a $75 return fee. In the case 8% of devices came back, and refunds took $163,717 off FY2026 revenue. Price, margin and break-even are read per device kept.
Raising conversion at the first site by five points in FY2026, at the year's mix and prices, means 58 more fitted patients, 104 more devices and 96 kept after returns.
Revenue with follow-ups and accessories = $211,779
Less cost of goods $72,776, card fees $4,605 and the associate's commission with burden $4,464
Contribution = $129,934 a year
The case does not say whether the schedule could hold that many more fittings and follow-ups without another hire, which is the first question before counting on the money.
| Line | FY2025 | FY2026 |
|---|---|---|
| Revenue | $1,411,472 | $2,159,690 |
| Gross margin | $909,159 (64.4%) | $1,461,331 (67.7%) |
| Site operating expenses | $556,612 | $812,181 |
| Company overhead (owner's salary included) | $146,580 | $160,044 |
| EBITDA | $205,967 (14.6%) | $489,106 (22.6%) |
| Depreciation, amortization and interest | $190,529 | $233,705 |
| Net income | $15,438 | $255,401 |
The owner, an audiologist with 16 clinic days a month, drew a salary of $132,000 in FY2026 plus $90,000 of distributions ($120,000 and $75,000 in FY2025). Before any pay to her the practice earned $637,150 in FY2026: seller's discretionary earnings (SDE), EBITDA plus the owner's salary and its burden, the figure a buyer starts from, as the article on what an audiology practice is worth shows. Interest and amortization are large because the practice was bought with debt, which the article on how to buy an audiology practice walks through.
Break-even is the number of hearing aids kept a month at which what each device kept leaves after its variable costs (cost of goods, card fees and the associate's commission with burden), carrying the diagnostic fees, follow-ups and accessories that come with it, covers the month's fixed costs, company overhead included. At the first site in FY2026:
Break-even = $57,405 of fixed costs a month ÷ $1,494.89 a device kept = 39 devices kept a month (rounded up), against an actual average of 67. This is a break-even of EBITDA: add the first site's loan payments ($13,873 a month on the purchase loan and the manufacturer's loan) and it rises to 48, still below the actual.
Rules checked on 18 November 2026, federal only, and not legal, tax, accounting or clinical advice. Pellastone Hearing Care, its bank, lessor, landlord, manufacturer and buyer are fictional: every case figure is a teaching assumption, not a market norm. State law is for counsel in the practice's state.
No market figure is given here because none was verified from a primary source. In the book's fictional case one site made $1,411,472 of revenue in its first year, and $2,159,690 the next year with a second site open for six months; hearing aids after returns were 87.9% of it.
In the case the owner drew a salary of $132,000 in FY2026 and $90,000 of distributions, on EBITDA of $489,106 after her salary. Before any pay to her the practice earned $637,150 (SDE). Loan payments come out of the rest.
No. Under 42 CFR 411.15(d), as in force in November 2026, traditional Medicare excludes hearing aids and examinations to prescribe, fit or change them. A covered diagnostic evaluation by a qualified audiologist may be billed; the device and its fitting are paid by the patient or a plan's own benefit.
No benchmark is given here. In the case the hearing aid gross margin was 65.7% of hearing aid revenue at the first site in FY2026, after returns and the manufacturer's return fees, and EBITDA was 22.6% of the practice's revenue.
This article is one chapter's worth of arithmetic from The Audiology Practice Owner, which follows one fictional two-site hearing care practice for 24 months: the purchase with an SBA 7(a) loan, diagnostics and Medicare's hearing aid exclusion, bundled and unbundled prices, conversion, returns and device margin, over-the-counter hearing aids, associate pay, a manufacturer's loan, break-even, a second location and a manufacturer-affiliated group's letter of intent.
DRM-free PDF, $19.99 · Paperback, $32.99, shipped worldwide · Free calculator